has recently read a story on LancasterOnline.com that might interest you.
<YOUR PERSONAL MESSAGE GOES HERE>
Court: Can drug firms pay to delay generics?
, BY JESSE J. HOLLAND and LINDA A. JOHNSON, Associated Press
WASHINGTON -- Federal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs. They argue that these deals deny American consumers, usually for years, steep price declines that can top 90 percent.
The LancasterOnline.com Team
This is an automated message via LancasterOnline.com.